About PrecisionLife
We're a precision medicine company committed to predicting, treating, and preventing the world's most complex and costly diseases
A new era of precision medicine
Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.
These differences cannot be understood by traditional genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.
Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.
Until now...
Putting people at the center of their health
We've completely reimagined how to analyze patient data.
Using our Combinatorial Analytics & AI platform we are the first company to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.
This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on their biology.
Increasing success for clinical trials, treatments and patients.
-min%20(1).png)
.png)
Clinically actionable insights
We bring precision to every stage of the biopharma and healthcare value chain – guided by our unique insights into the mechanisms driving disease to connect the right patients with the right targets, trials and treatments.
Our science
We've completely reimagined how to analyze multiomic patient data to stratify complex chronic disease biology at unprecedented resolution – driving precision medicine.
Our team
Led by Dr Steve Gardner, a global leader in precision medicine & human genetics, and supported by a leadership team with vast experience and expertise.
